Cited by 988Neutrophil, Myeloperoxidase and Oxidative MechanismsImmune cells in cancerCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; none of the 27 sources its claims cite is checked for support yet.

Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps

Open access

Abstract

Treatment with DNase I–coated nanoparticles prevents metastasis by targeting neutrophil extracellular traps induced by cancer cells in a mouse model.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Metastatic breast cancer cells induce neutrophils to form NETs in the absence of infection, and these NETs promote cancer cell invasion and lung metastasis. Digesting NETs with DNase I-coated nanoparticles reduced metastatic burden in mice, suggesting NETs as a therapeutic target.

Key findings

  • In mice, metastatic 4T1 cells induced NET-like extracellular DNA structures in the lungs, with neutrophil elastase activity co-localizing with extracellular DNA in 14 of 17 imaged fields after 4T1 injection but not after non-metastatic 4T07 injection (p=0.0008).
  • In human breast cancer samples, NETs were detected in 16 of 20 primary tumors and 13 of 19 metastatic lung lesions; the highest numbers were in triple-negative tumors (6 of 6 primary tumors and 7 of 7 metastases), with absent or very low numbers in luminal cancers.
  • NETs stimulated breast cancer cell invasion and migration in vitro; DNase I digestion blocked these effects. Cancer cell-induced NET formation required G-CSF, NADPH oxidase, PAD4, cathepsin G, and neutrophil elastase, and occurred through a lytic process.
  • DNase I-coated nanoparticles significantly reduced experimental lung metastasis: 3 of 9 treated mice had no detectable metastasis versus all 10 control mice, with reduced metastatic foci number (p=0.0003) and average foci size (p=0.01). In spontaneous metastasis, 3 of 6 treated mice had no detectable metastases versus all control mice having micrometastases, with no effect on primary tumor growth.

Methods

  • In vitro transwell invasion/migration and NET-formation assays used murine 4T1, 4T07, and C3(1)-Tag breast cancer cells and human BT-549 cells with mouse or human neutrophils, plus inhibitors, blocking antibodies, DNase I, conditioned medium, immunofluorescence, and electron microscopy.
  • In vivo studies used confocal intravital lung imaging (CILI) in LysM-EGFP mice, experimental and spontaneous 4T1 metastasis models in BALB/c mice, and daily intraperitoneal DNase I-coated nanoparticles (75 U/mouse); clinical breast cancer samples were analyzed by immunofluorescence.
  • Statistical analyses used GraphPad Prism with two-sided t-tests or one-way ANOVA at alpha 0.05; some assessments were blinded, and sample sizes are in figure legends.

Limitations

  • Stated: the p47phox−/− strain is on the C57BL/6 background, precluding in vivo experiments with BALB/c-derived 4T1 cells.
  • Stated: long-term PAD4 inhibition could not be tested for metastasis because commercially available PAD4 inhibitors have serum half-lives of ∼15 min–4 h, so DNase I-coated nanoparticles could not be compared with PAD4 inhibition as strategies.
  • Stated/evident: the clinical sample panel was small, and the paper notes that assays are needed to identify patients who may benefit from NET-targeted treatments; it also states that whether NETs participate in migration and invasion in the primary tumor remains a future direction.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aag1711

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

67 Own result · 27 Own interpretation · 22 Not checked yet · 7 Own method · 1 No basis given

Verify all 27 references — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 19
40 of 40
  • The paper relies on this without support.

    The immunofluorescence staining used on human clinical samples detects NETs specifically.

    “To determine whether NETs could also be found in metastatic human breast cancer, we performed immunofluorescence staining on a small panel of clinical samples of primary tumor and matched metastatic lung lesions from breast cancer patients (Fig. 2A).”
  • The paper relies on this without support.

    The number of histologically detectable metastatic foci reflects expansion of disseminated cancer cells rather than initial seeding.

    “Unexpectedly, cancer cell-induced NETs did not promote extravasation but did influence the number of histologically detectable metastatic foci. This suggests that NETs mediate the expansion of disseminated cells.”
  • The paper relies on this without support.

    The mouse models used reflect human breast cancer metastasis.

    “To investigate whether neutrophils play a role in metastasis, we first compared neutrophil infiltration into tumors from orthotopically transplanted 4T1 and 4T07 murine breast cancer cells.”
  • The paper relies on this without support.

    DNase I-coated nanoparticles reduce metastasis specifically by digesting NETs.

    “Daily intraperitoneal injection of DNase I-coated nanoparticles significantly (p=0.002) reduced metastatic burden after intravenous injection of 4T1 cells (Figs. 6C, D).”
  • The paper relies on this without support.

    Cancer cells can acquire the ability to invade and migrate through many other means.

    “but cancer cells can acquire the ability to invade and migrate through many other means.”
  • The paper relies on this without support.

    4T1 cells and C3(1)-Tag tumors are both models of triple-negative breast cancer.

    “and they are both models of triple-negative breast cancer.”
  • The paper relies on this without support.

    Metastasis accounts for the great majority of cancer-associated deaths.

    “which accounts for the great majority of cancer-associated deaths.”
7 of 7

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Cited by

Sorted by citations

See all 988

Metadata

Authors
Park, J., Wysocki, R. W., Amoozgar, Z., Maiorino, L., Fein, M. R., Jorns, J., Schott, A. F., Kinugasa-Katayama, Y., Lee, Y., Won, N. H., Nakasone, E. S., Hearn, S. A., Küttner, V., Qiu, J., Almeida, A. S., Perurena, N., Kessenbrock, K., Goldberg, M. S., & Egeblad, M.
Affiliations
  • Cold Spring Harbor Laboratory (US)
  • Dana-Farber Cancer Institute (US)
  • University of Michigan (US)
  • Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
  • Korea University Anam Hospital (KR)
  • St Giles Foundation (US)
  • University of California, Irvine (US)
  • Harvard University (US)
Corresponding author
  • Park, Juwon
  • Wysocki, Robert W.
  • Amoozgar, Zohreh
  • Maiorino, Laura
  • Perurena, Naiara
  • Egeblad, Mikala
Venue
Science Translational Medicine
Published
2016-10-19
Volume
8
Issue
361
Pages
361ra138-361ra138
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2534066964
Cited by
984
References
50
Citations by year
2026: 84 · 2025: 134 · 2024: 137 · 2023: 109 · 2022: 120 · 2021: 133 · 2020: 117 · 2019: 73 · 2018: 48 · 2017: 24 · 2016: 3
FWCI
29.92
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • CSHL Cancer Center Support (5P30CA045508)
  • U.S. Department of Defense (W81XWH-14-1-0078)
  • Long Island 2-Day Walk to Fight Breast Cancer
  • Joni Gladowsky Breast Cancer Foundation
  • NIH (5U01CA180944-02)
  • Hope Foundation
  • Cancer Research Institute
  • National Institute of General Medical Sciences Medical Scientist Training Program Training Award (T32-GM008444)
  • Aid for Cancer Research
  • Boehringer Ingelheim Fonds
  • Formación de Profesorado Universitario (AP2010-2197)
  • National Cancer Institute (K99 CA181490)
  • Deutsche Forschungsgemeinschaft (KU 3264/1-1)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
neutrophil extracellular traps, breast cancer metastasis, tumor-host interaction, DNase I, lung metastasis, tumor invasion, tumor cell migration, triple-negative breast cancer, intravital imaging
MeSH terms
Animals, Cell Movement, Deoxyribonuclease I, Humans, Lung, Lung Neoplasms, Mice, Inbred BALB C, Neoplasm Metastasis, Neutrophils, Cell Line, Tumor, Mice, Nanoparticles, Triple Negative Breast Neoplasms, Extracellular Traps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review